Fact CheckerSign in

NCT06199154RecruitingEarly phase 1

Induction of Labor in Morbidly Obese Patients

Induction of Labor in Morbidly Obese Patients: Comparison of 50 mcg and 25 mcg Misoprostol - A Randomized Control Trial

Source: ClinicalTrials.gov · Last updated 29 Jul 2026

Brief summary (registry, in English)

The goal of this randomized control trial is to compare different doses of Misoprostol (25 mcg vs 50 mcg) in induction of labor (IOL) in morbidly obese patients with BMI \>40. It is known that morbid obesity is a risk factor for failed IOL and ultimately cesarean delivery (CD.) If the rates of vaginal delivery in this population can improve, then surgical morbidity can be reduced in these patients.

Status (registry)
Recruiting
Phase (registry)
Early phase 1
Study type
Interventional
Enrollment
162 (estimated)
First submitted
4 Dec 2023
Start date
Jul 2024
Primary completion date
Dec 2026
Lead sponsor
University of Maryland, Baltimore
Diseases
Obesity
NCT number
NCT06199154

What you commit to

  • Study type: Interventional · Early phase 1
  • Planned participants: 162
  • From Jul 2024 to the primary completion date, Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Contraindication to prostaglandin administration (significant myomectomy, prior cesarean delivery)

Other illness

  • History of cesarean delivery
  • Contraindication to vaginal delivery (placenta previa, vasa previa, HIV with high viral load)
  • Contraindications to labor (cardiac, neurosurgical, need for cesarean)
  • Significant vaginal bleeding with concern for placental abruption
  • Non-reassuring fetal status or fetal heart rate decelerations

Age

  • Age \< 18yo

Other

  • Fetal growth restriction with abnormal umbilical artery Doppler indices
  • Cervical dilation \>5 cm
  • Contractions \>5 per 10 minutes
  • Fetal demise or major fetal anomaly
  • Inability to give consent

Who the study is looking for

  • Morbidly obese (BMI ≥ 40 kg/m2) at admission for induction of labor
  • Speaks English or Spanish
  • Gestational age between 34 weeks and 0 days and 42 weeks and 6 days
  • Age 18 years old or older
  • Viable, single, cephalic fetus
  • Intent to proceed with cervical ripening - cervical exam: dilation \< 5 cm
  • Contractions \< 5 per 10 minutes

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Maryland Medical Center
Coordinator of this site? Confirm its status
BaltimoreUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.